De Brauw Blackstone Westbroek and Latham & Watkins represented Digital Realty in the transaction. Digital Realty Trust, LP (NYSE listed) has entered into a sale and...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Spectrum Pharmaceuticals in the deal. Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, has entered into...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Extra Space in the transaction. Extra Space Storage Inc. and its subsidiaries (collectively Extra Space or the Company) (NYSE: EXR) has completed...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Alignment Healthcare in the transaction. Alignment Healthcare, Inc.(Alignment Healthcare) (NASDAQ: ALHC), a leading tech-enabled MedicareAdvantage company, has announced the close of an...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented InBrace in the transaction. Horizon Technology Finance Corporation (NASDAQ: HRZN) (Horizon) has announced the close of a US$45 million growth facility...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Ardelyx, Inc. in the transaction in the transaction. Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented TorQuest Partners and CDPQ in the transaction. Torys LLP assisted Barrette and its sellers, TorQuest and CDPQ. CRH plc, the global leader in...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Ouster, Inc. on the deal. Ouster, Inc., a leading lidar technology developer, executed an up to US$50 million structured debt facility from Hercules...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised BridgeBio on the deal. BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, has entered into...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Kennedy Lewis Investment Management LLC in the transaction. Impulse Dynamics, a global medical device company a medical device company organized in Curacao...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Extra Space in the offering. Extra Space Storage Inc., a leading owner and operator of self-storage facilities in the United States and a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented SLR Investment Corp. in the transaction. Vapotherm, Inc., a global medical technology company focused on the development and commercialization of non-invasive technologies...
You must be a Standard 1 Year member to access this content.
